Stroke Risk and Treatment in Patients with Atrial Fibrillation and Low CHA₂DS₂-VASc Scores: Findings From the ORBIT-AF I and II Registries.

ABSTRACT: Background Current American College of Cardiology/American Heart Association guidelines suggest that for patients with atrial fibrillation who are at low risk for stroke (CHA₂DS₂VASc=1) (or women with CHA₂DS₂VASc=2) a variety of treatment strategies may be considered. However, in clinical practice, patterns of treatment in these "low-risk" patients are not well described. The objective of this analysis is to define thromboembolic event rates and to describe treatment patterns in patients with low-risk CHA₂DS₂VASc scores. Methods and Results We compared characteristics, treatment strategies, and outcomes among patients with a CHA₂DS₂VASc=0, CHA₂DS₂VASc=1, females with a CHA₂

SUBMITTER: Jackson LR 

PROVIDER: S-EPMC6201408 | biostudies-literature | 2018 Aug

REPOSITORIES: biostudies-literature